Potential treatments for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases may already be out there in ...

With a Trump-driven reduction of nearly 2,000 employees, agency officials view artificial intelligence as a way to speed ...

UW Health's Dr. Jeff Pothof discusses the FDA's authorization of the first artificial intelligence platform for breast cancer ...

In JAMA, the FDA's Makary and Prasad said they will focus on modernizing review processes and lowering drug costs but don't outright mention precision medicine.

A former FDA reviewer offers advice to help innovative medtech avoid new and more dangerous pitfalls as experts leave the ...

The new FDA commissioner and Center for Biologics Evaluation and Research (CBER) director laid out their vision for the ...

FDA approves CLAIRITY BREAST, a new AI breast cancer prediction tool that helps doctors assess five-year risk from routine ...

More and more devices using AI and machine learning technology are becoming available for purchase, something that’s just as ...

AI may provide an answer to the question of whether drugs initially developed and prescribed for non-neurodegenerative physical conditions can be used to treat individuals with Parkinson’s disease.

The FDA announced last week it launched Elsa, an AI tool designed to help employees work better. AI also is impacting ...